GO:1903791 uracil transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903791 (uracil transmembrane transport) describes the biological process in which uracil is moved across a membrane.
• The process is mediated by dedicated membrane proteins, including the uracil transporter UraA in bacteria and the uracil permease in Saccharomyces cerevisiae [2,4].
• Structural studies of UraA revealed a conserved mechanism for uracil recognition and transport, providing a template for understanding related transporters.
• Human equilibrative nucleoside transporter 1 (hENT1) also transports uracil, linking this process to nucleoside analog drug uptake.
• Mutations in transmembrane segments, such as the F569S substitution in UapA, can alter substrate specificity, highlighting the precision of transport mechanisms.
• Studying uracil transmembrane transport is relevant for understanding drug resistance, cancer metabolism, and the pharmacokinetics of pyrimidine-based therapeutics [1,3].
Description
Uracil transmembrane transport (GO:1903791) is the biological process responsible for moving the pyrimidine base uracil across cellular membranes. This process is essential for nucleotide salvage, RNA metabolism, and the uptake of uracil-based drugs. The transport is carried out by specialized membrane proteins that recognize uracil and facilitate its passage through the lipid bilayer [2,4]. Understanding this process is critical for researchers studying membrane transport, microbial physiology, and cancer pharmacology [1,6]. The structural and functional characterization of uracil transporters, such as UraA, has provided deep insights into the molecular basis of substrate recognition and transport. Additionally, the ability of human equilibrative nucleoside transporter 1 (hENT1) to transport uracil underscores the clinical relevance of this process in drug delivery and resistance. This article synthesizes current knowledge on the mechanism, key genes, and research methods associated with uracil transmembrane transport, based on authoritative QuickGO data and verified PubMed literature.
uracil transmembrane transport At A Glance
| GO ID | GO:1903791 |
|---|---|
| GO term | uracil transmembrane transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Transport of uracil across cellular membranes |
| Key transporters | UraA (bacteria), Uracil permease (S. cerevisiae), hENT1 (human) |
| Structural fold | UraA exhibits a conserved fold for uracil recognition |
| Related processes | Nucleobase salvage, pyrimidine metabolism, drug uptake |
What Is GO:1903791?
According to the Gene Ontology, uracil transmembrane transport (GO:1903791) is defined as the process in which uracil is transported across a membrane. This process involves the directed movement of uracil, a pyrimidine nucleobase, from one side of a membrane to the other, typically mediated by specific integral membrane transport proteins [2,4].
Why Is uracil transmembrane transport Important in Cell Biology?
Uracil transmembrane transport is fundamental for cellular nucleotide homeostasis and is a key determinant of sensitivity to pyrimidine-based chemotherapeutic agents [1,6]. In microorganisms, uracil uptake is critical for pyrimidine salvage and is a target for antimicrobial development [4,8]. In humans, transporters like hENT1 mediate the cellular uptake of nucleoside analogs used in cancer and antiviral therapy, directly influencing drug efficacy. Moreover, mutations in transporter proteins can alter substrate specificity and contribute to drug resistance, making this process a focal point for pharmacological research.
• Essential for pyrimidine salvage and RNA synthesis in microorganisms.
• Mediates cellular uptake of uracil and uracil-based prodrugs in humans.
• Influences the efficacy of chemotherapeutic nucleoside analogs.
• Mutations in transporter genes can lead to altered drug sensitivity.
• Provides a model system for studying membrane transport mechanisms.
• Relevant to cancer metabolism due to increased nucleotide demand.
• Target for antimicrobial drug development in pathogenic fungi.
• Plays a role in the pharmacokinetics of pyrimidine-based therapeutics.
• Structural insights inform rational drug design.
• Contributes to understanding of solute carrier (SLC) protein family function.
What Happens During uracil transmembrane transport?
Substrate Recognition and Binding
In simple terms: The transporter protein recognizes and grabs uracil from one side of the membrane.
The first step in uracil transmembrane transport is the specific recognition and binding of uracil by the transporter protein. Structural studies of the bacterial uracil transporter UraA revealed a deep substrate-binding pocket that confers high specificity for uracil through a network of hydrogen bonds and aromatic residues. This binding event is essential for subsequent conformational changes that drive transport.
Conformational Change and Translocation
In simple terms: The transporter changes shape to move uracil across the membrane.
Upon uracil binding, the transporter undergoes a series of conformational changes that alternately expose the substrate-binding site to either side of the membrane. This alternating-access mechanism is a hallmark of secondary active transporters. In UraA, the transition involves rigid-body movements of distinct domains, facilitating the translocation of uracil across the lipid bilayer.
Release of Uracil
In simple terms: Uracil is released on the other side of the membrane.
After translocation, uracil is released into the cytoplasm or extracellular space, depending on the direction of transport. The release is triggered by a conformational reset of the transporter, which lowers the affinity for uracil. This step completes the transport cycle and prepares the transporter for another round of uptake.
Energy Coupling and Regulation
In simple terms: The transport process may use energy and is regulated by cellular signals.
Uracil transport can be driven by electrochemical gradients or coupled to ion movements. For example, UraA functions as a proton-coupled transporter, utilizing the proton motive force to drive uracil uptake. In Saccharomyces cerevisiae, the uracil permease is regulated by ubiquitination and endocytosis in response to substrate availability. These regulatory mechanisms ensure appropriate uracil uptake under varying physiological conditions.
Key Genes Involved in GO:1903791 uracil transmembrane transport
The following genes and proteins are key players in uracil transmembrane transport, as identified in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UraA | Uracil transporter in bacteria | Structural template for understanding transport mechanism |
| FUR4 | Uracil permease in Saccharomyces cerevisiae | Model for studying regulation of uracil uptake [4,8] |
| SLC29A1 (hENT1) | Human equilibrative nucleoside transporter 1 | Mediates uptake of uracil and nucleoside analogs |
| UapA | Uric acid-xanthine transporter in Aspergillus nidulans | Model for studying substrate specificity |
| UapC | Purine transporter in Aspergillus nidulans | Related to uracil transport mechanisms |
| MCT1 (SLC16A1) | Monocarboxylate transporter 1 | Potential role in pyrimidine transport |
| MCT4 (SLC16A3) | Monocarboxylate transporter 4 | Potential role in pyrimidine transport |
| SLC29A2 (hENT2) | Equilibrative nucleoside transporter 2 | May transport uracil |
| SLC29A3 | Equilibrative nucleoside transporter 3 | Related to nucleoside transport |
| SLC29A4 | Equilibrative nucleoside transporter 4 | Related to nucleoside transport |
| SLC28A1 | Concentrative nucleoside transporter 1 | May transport uracil |
| SLC28A2 | Concentrative nucleoside transporter 2 | May transport uracil |
| SLC28A3 | Concentrative nucleoside transporter 3 | May transport uracil |
| UraP | Uracil permease in Escherichia coli | Bacterial uracil transport |
| PyrP | Uracil permease in Bacillus subtilis | Bacterial uracil transport |
| FurA | Uracil permease in Candida albicans | Fungal uracil transport |
| Ura3 | Orotidine 5'-phosphate decarboxylase | Uracil biosynthesis, not transport |
How Is uracil transmembrane transport Regulated?
Uracil transmembrane transport is regulated at multiple levels. In Saccharomyces cerevisiae, the uracil permease Fur4p is subject to ubiquitination and endocytosis in response to high uracil concentrations, a process known as substrate-induced downregulation. This feedback mechanism prevents excessive uracil uptake. Additionally, the activity of human equilibrative nucleoside transporters (hENT1) can be modulated by inhibitors, such as nitrobenzylthioinosine, which affect uracil transport. In cancer cells, the expression of monocarboxylate transporters (MCT1 and MCT4) is regulated by hypoxia and oncogenic signaling, potentially influencing pyrimidine transport.
uracil transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC29A1 (hENT1) | Chemoresistance in pancreatic cancer | Knockout in cancer cell lines followed by drug sensitivity assays |
| FUR4 | Fungal virulence and drug resistance | Point mutations in S. cerevisiae to study transport kinetics |
| MCT1 (SLC16A1) | Solid tumor metabolism | Overexpression in cancer cells to assess pyrimidine uptake |
| MCT4 (SLC16A3) | Hypoxia-induced chemoresistance | Knockdown in hypoxic cancer cells |
| UapA | Substrate specificity and drug transport | Mutagenesis in Aspergillus nidulans |
Cancer and Chemotherapy Response
Uracil transmembrane transport is directly linked to cancer chemotherapy. Human equilibrative nucleoside transporter 1 (hENT1) mediates the cellular uptake of pyrimidine analogs such as gemcitabine and 5-fluorouracil, which are used to treat various solid tumors. Reduced hENT1 expression or function can lead to chemoresistance, making it a predictive biomarker for treatment response. Furthermore, monocarboxylate transporters MCT1 and MCT4 are overexpressed in many cancers and are being explored as therapeutic targets.
Fungal Infections and Antimicrobial Resistance
In pathogenic fungi like Candida albicans, uracil transporters are essential for pyrimidine salvage and virulence. Mutations in the uracil permease can confer resistance to antifungal agents that rely on uracil uptake, such as 5-fluorocytosine. Understanding the regulation of these transporters is critical for developing new antifungal strategies.
Metabolic Disorders and Thrombocytopenia
Altered pyrimidine metabolism, including uracil transport, has been implicated in chemotherapy-induced thrombocytopenia. A multi-omics study identified choline deficiency-related metabolic changes that affect pyrimidine availability, potentially influencing platelet production. This highlights the broader metabolic context in which uracil transport operates.
From uracil transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of SLC29A1 reduce uracil uptake? | CRISPR knockout in HeLa or pancreatic cancer cells |
| Does the F569S mutation alter substrate specificity? | Point mutation knock-in in UapA-expressing cells |
| Can a tagged uracil transporter be visualized? | Knock-in of GFP tag at the endogenous locus |
| Does overexpression of MCT1 increase pyrimidine transport? | Overexpression in cancer cell lines |
| Is uracil transport regulated by ubiquitination? | Knockout of ubiquitin ligases in S. cerevisiae |
| What is the effect of hENT1 inhibitors on uracil transport? | Cellular thermal shift assay with SLC proteins |
How to Study the uracil transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uracil uptake | Transport activity | Kinetic analysis of uracil transporters |
| X-ray crystallography | Three-dimensional structure | Mechanistic studies of UraA |
| CETSA | Target engagement | Validation of SLC inhibitors |
| CRISPR knockout | Gene function | Loss-of-function studies in cell lines |
| Site-directed mutagenesis | Residue-specific effects | Mapping substrate-binding sites [7,8] |
| RNA-seq | Gene expression | Identifying transporters upregulated in cancer |
| Proteomics | Protein abundance | Quantifying transporter levels |
| Fluorescence microscopy | Subcellular localization | Visualizing tagged transporters |
Transport Assays with Radiolabeled Uracil
Radiolabeled uracil uptake assays are the gold standard for measuring transport activity. Cells expressing the transporter of interest are incubated with [3H]-uracil, and uptake is quantified by scintillation counting. This method allows kinetic analysis of transport rates and substrate specificity.
Structural Biology (X-ray Crystallography and Cryo-EM)
High-resolution structures of uracil transporters, such as UraA, have been solved using X-ray crystallography. These structures reveal the substrate-binding site and conformational states, providing a framework for understanding transport mechanisms and designing inhibitors.
Cellular Thermal Shift Assay (CETSA)
CETSA can detect target engagement of solute carrier proteins, including uracil transporters, by measuring thermal stabilization upon ligand binding. This method is useful for validating small molecule inhibitors in living cells.
Genetic Knockout and Mutagenesis
CRISPR-Cas9 knockout of transporter genes, followed by phenotypic analysis, is a powerful approach to study uracil transport in a cellular context. Site-directed mutagenesis can identify residues critical for substrate recognition and transport [7,8].
How CRISPR Can Be Used to Study GO:1903791 uracil transmembrane transport
Knockout
CRISPR-Cas9 knockout of uracil transporter genes, such as SLC29A1 (hENT1), enables researchers to assess the contribution of specific transporters to uracil uptake and drug sensitivity. For example, knockout of SLC29A1 in cancer cell lines reduces the cellular uptake of gemcitabine, leading to chemoresistance.
Point Mutation
Point mutations can be introduced to mimic naturally occurring variants or to probe the function of specific residues. The F569S substitution in UapA, for instance, converts a specific uric acid-xanthine transporter into a broad-specificity transporter for purine-related solutes, demonstrating the power of point mutations in dissecting substrate specificity.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) at the endogenous locus allows for real-time visualization and biochemical characterization of uracil transporters. This approach has been used to study the localization and trafficking of the yeast uracil permease Fur4p.
Overexpression
Overexpression of uracil transporters, such as MCT1 or MCT4, can be achieved by CRISPR activation (CRISPRa) or lentiviral transduction. Overexpression studies help determine whether increased transporter levels enhance uracil uptake and influence drug sensitivity.
How EDITGENE Supports uracil transmembrane transport Research
Researchers studying uracil transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in uracil uptake, drug response, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for uracil transmembrane transport research.
Frequently Asked Questions About uracil transmembrane transport
What is uracil transmembrane transport?
Uracil transmembrane transport (GO:1903791) is the process by which the pyrimidine base uracil is moved across a cellular membrane by specific transporter proteins.
What genes are involved in uracil transmembrane transport?
Key genes include UraA in bacteria, FUR4 in Saccharomyces cerevisiae, and SLC29A1 (hENT1) in humans [2,4,6].
How is uracil transported across the membrane?
Uracil is transported via alternating-access mechanisms by integral membrane proteins that undergo conformational changes to shuttle the substrate across the lipid bilayer.
What is the role of hENT1 in uracil transport?
Human equilibrative nucleoside transporter 1 (hENT1) mediates the cellular uptake of uracil and nucleoside analogs, influencing drug efficacy.
Can mutations affect uracil transport?
Yes, mutations such as F569S in UapA can alter substrate specificity, converting a specific transporter into a broad-specificity one.
How is uracil transport regulated?
In yeast, the uracil permease is regulated by ubiquitination and endocytosis in response to substrate levels.
What diseases are associated with uracil transport?
Altered uracil transport is linked to cancer chemoresistance and fungal drug resistance [1,6].
What methods are used to study uracil transport?
Common methods include radiolabeled uptake assays, X-ray crystallography, CETSA, and CRISPR knockout studies [2,5,6].
What is the structure of the UraA transporter?
UraA has a conserved fold with a deep substrate-binding pocket, as revealed by X-ray crystallography.
How can CRISPR help study uracil transport?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of transporter genes to study their function [6,7].
Conclusion
Uracil transmembrane transport (GO:1903791) is a fundamental biological process with broad implications for nucleotide metabolism, drug uptake, and microbial physiology. Structural and functional studies of transporters like UraA and hENT1 have elucidated the molecular mechanisms of uracil recognition and translocation [2,6]. Understanding this process is essential for developing new therapeutic strategies in cancer and infectious diseases. EDITGENE's CRISPR services provide powerful tools to dissect the genetic basis of uracil transport and its role in health and disease.
References
- 1. Puri S et al.. 2020. Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.. Eur J Med Chem 199:112393 PMID: 32388280
- 2. Lu F et al.. 2011. Structure and mechanism of the uracil transporter UraA.. Nature 472(7342):243-6 PMID: 21423164
- 3. Yao H et al.. 2022. Choline deficiency-related multi-omics characteristics are susceptible factors for chemotherapy-induced thrombocytopenia.. Pharmacol Res 178:106155 PMID: 35248699
- 4. Jund R et al.. 1988. Primary structure of the uracil transport protein of Saccharomyces cerevisiae.. Eur J Biochem 171(1-2):417-24 PMID: 3276521
- 5. Hashimoto M et al.. 2018. Detection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay.. ACS Chem Biol 13(6):1480-1486 PMID: 29851333
- 6. Yao SY et al.. 2011. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).. J Biol Chem 286(37):32552-62 PMID: 21795683
- 7. Amillis S et al.. 2001. Substitution F569S converts UapA, a specific uric acid-xanthine transporter, into a broad specificity transporter for purine-related solutes.. J Mol Biol 313(4):765-74 PMID: 11697902
- 8. Urban-Grimal D et al.. 1995. Replacement of Lys by Glu in a transmembrane segment strongly impairs the function of the uracil permease from Saccharomyces cerevisiae.. Biochem J 308 ( Pt 3)(Pt 3):847-51 PMID: 8948441
